HUE054542T2 - Glükokortikoid receptor inhibitor - Google Patents
Glükokortikoid receptor inhibitorInfo
- Publication number
- HUE054542T2 HUE054542T2 HUE17859300A HUE17859300A HUE054542T2 HU E054542 T2 HUE054542 T2 HU E054542T2 HU E17859300 A HUE17859300 A HU E17859300A HU E17859300 A HUE17859300 A HU E17859300A HU E054542 T2 HUE054542 T2 HU E054542T2
- Authority
- HU
- Hungary
- Prior art keywords
- inhibitor
- glucocorticoid receptor
- glucocorticoid
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662405801P | 2016-10-07 | 2016-10-07 | |
US201762526331P | 2017-06-28 | 2017-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE054542T2 true HUE054542T2 (hu) | 2021-09-28 |
Family
ID=61832215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17859300A HUE054542T2 (hu) | 2016-10-07 | 2017-10-06 | Glükokortikoid receptor inhibitor |
Country Status (20)
Country | Link |
---|---|
US (5) | US10472387B2 (hu) |
EP (2) | EP3523315B1 (hu) |
JP (2) | JP6801093B2 (hu) |
KR (2) | KR102237916B1 (hu) |
CN (2) | CN111690031B (hu) |
AU (3) | AU2017339510B2 (hu) |
BR (1) | BR112019006987B1 (hu) |
CA (1) | CA3039636C (hu) |
DK (1) | DK3523315T3 (hu) |
ES (1) | ES2867853T3 (hu) |
HU (1) | HUE054542T2 (hu) |
IL (2) | IL265835B (hu) |
MX (2) | MX2019004030A (hu) |
NZ (1) | NZ753142A (hu) |
PL (1) | PL3523315T3 (hu) |
PT (1) | PT3523315T (hu) |
SG (1) | SG11201903055UA (hu) |
SI (1) | SI3523315T1 (hu) |
WO (1) | WO2018068021A1 (hu) |
ZA (1) | ZA202004440B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11208432B2 (en) | 2015-12-23 | 2021-12-28 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
WO2017112904A1 (en) | 2015-12-23 | 2017-06-29 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
AU2016377702B2 (en) | 2015-12-23 | 2021-03-11 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
CN111690031B (zh) | 2016-10-07 | 2021-06-01 | 欧瑞克制药公司 | 糖皮质激素受体抑制剂 |
AU2019252561A1 (en) * | 2018-04-11 | 2020-11-26 | Oric Pharmaceuticals, Inc. | Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereof |
WO2021163273A1 (en) * | 2020-02-12 | 2021-08-19 | Oric Pharmaceuticals, Inc. | Uses of glucocorticoid receptor antagonists |
US20230212215A1 (en) * | 2020-05-08 | 2023-07-06 | Trustees Of Dartmouth College | Glucocorticoid receptor modulators |
CN115915529A (zh) * | 2021-09-30 | 2023-04-04 | 赛万特科技有限责任公司 | 发光控制方法、发光控制装置及发光装置 |
CN114230627B (zh) * | 2021-12-31 | 2023-09-15 | 湖南新合新生物医药有限公司 | 一种倍他米松环氧水解物中间体的制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA8231B (en) | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
FR2528434B1 (fr) | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
FR2522328B1 (fr) | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
BE1004905A4 (fr) | 1987-12-30 | 1993-02-23 | Roussel Uclaf | Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
JPH02188599A (ja) | 1988-11-16 | 1990-07-24 | Roussel Uclaf | 3―ケト―デルタ―4,9―19―ノルステロイドから誘導される新物質及びそれらよりなる薬剤 |
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
FR2651435A1 (fr) | 1989-09-07 | 1991-03-08 | Roussel Uclaf | Nouvelle utilisation de composes anti-progestomimetiques. |
DE4018167A1 (de) * | 1990-06-01 | 1991-12-05 | Schering Ag | Verfahren zur herstellung von 10(beta)-h-steroiden |
DE4042007A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | 6,7-modifizierte-11(beta)-aryl-4-estrene |
ES2124905T3 (es) | 1993-08-04 | 1999-02-16 | Akzo Nobel Nv | Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad. |
WO1995017192A1 (en) | 1993-12-22 | 1995-06-29 | The Salk Institute For Biological Studies | Methods for reducing multidrug resistance |
ES2196063T3 (es) | 1995-02-02 | 2003-12-16 | Schering Ag | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. |
IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
IL122740A (en) * | 1997-01-15 | 2003-09-17 | Akzo Nobel Nv | 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them |
CN1085078C (zh) * | 1998-01-07 | 2002-05-22 | 沈志华 | 用于大月份引产的复合药物 |
US6512130B1 (en) * | 2000-09-05 | 2003-01-28 | Council Of Scientific And Industrial Research | Mifepristone analogue, process for the preparation thereof and use thereof |
EP1285927A3 (de) * | 2001-08-16 | 2005-06-29 | Schering Aktiengesellschaft | Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems |
US7250408B2 (en) * | 2002-12-16 | 2007-07-31 | Bayer Schering Pharma Ag | Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility |
ES2337521T3 (es) | 2006-02-17 | 2010-04-26 | Janssen Pharmaceutica N.V. | Derivados esteroides 17-fosforados utilizados como moduladores del receptor de la progesterona. |
KR101600230B1 (ko) | 2006-03-29 | 2016-03-04 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 디아릴티오히단토인 화합물 |
CA2684450C (en) | 2007-04-20 | 2017-05-30 | Preglem S.A. | Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding |
WO2012106514A2 (en) | 2011-02-03 | 2012-08-09 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
EP2545922A1 (en) | 2011-07-12 | 2013-01-16 | PregLem S.A. | Treatment of excessive menstrual bleeding associated with uterine fibroids |
US20130029953A1 (en) | 2011-07-28 | 2013-01-31 | Klaus Nickisch | Progesterone antagonists |
DK3111950T3 (da) | 2012-02-24 | 2021-10-04 | Univ Chicago | Fremgangsmåder og sammensætninger relateret til glucocorticoidreceptorantagonisme og prostatacancer |
EP2641602A1 (en) | 2012-03-23 | 2013-09-25 | PregLem S.A. | Method for treating gynecological diseases |
US9096641B2 (en) * | 2013-06-05 | 2015-08-04 | Evestra, Inc. | Imidazolyl progesterone antagonists |
US10919929B2 (en) * | 2013-12-11 | 2021-02-16 | Sloan-Kettering Institute For Cancer Research | Glucocorticoid inhibitors for treatment of prostate cancer |
CN104530166B (zh) | 2014-12-04 | 2016-08-24 | 陕西汉江药业集团股份有限公司 | 选择性还原4,6-共轭双烯-3-酮甾体化合物的方法 |
AU2016377702B2 (en) * | 2015-12-23 | 2021-03-11 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
US11208432B2 (en) * | 2015-12-23 | 2021-12-28 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
WO2017112904A1 (en) | 2015-12-23 | 2017-06-29 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
CN111690031B (zh) | 2016-10-07 | 2021-06-01 | 欧瑞克制药公司 | 糖皮质激素受体抑制剂 |
US20200179404A1 (en) | 2017-06-09 | 2020-06-11 | Regents Of The University Of Minnesota | Skin care formulations and skin cancer treatment |
AU2019252561A1 (en) | 2018-04-11 | 2020-11-26 | Oric Pharmaceuticals, Inc. | Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereof |
-
2017
- 2017-10-06 CN CN202010567003.9A patent/CN111690031B/zh active Active
- 2017-10-06 SG SG11201903055UA patent/SG11201903055UA/en unknown
- 2017-10-06 PT PT178593000T patent/PT3523315T/pt unknown
- 2017-10-06 PL PL17859300T patent/PL3523315T3/pl unknown
- 2017-10-06 AU AU2017339510A patent/AU2017339510B2/en active Active
- 2017-10-06 HU HUE17859300A patent/HUE054542T2/hu unknown
- 2017-10-06 ES ES17859300T patent/ES2867853T3/es active Active
- 2017-10-06 CA CA3039636A patent/CA3039636C/en active Active
- 2017-10-06 EP EP17859300.0A patent/EP3523315B1/en active Active
- 2017-10-06 NZ NZ753142A patent/NZ753142A/en unknown
- 2017-10-06 WO PCT/US2017/055660 patent/WO2018068021A1/en active Application Filing
- 2017-10-06 KR KR1020197013128A patent/KR102237916B1/ko active Application Filing
- 2017-10-06 CN CN201780075818.1A patent/CN110099915A/zh active Pending
- 2017-10-06 MX MX2019004030A patent/MX2019004030A/es unknown
- 2017-10-06 SI SI201730703T patent/SI3523315T1/sl unknown
- 2017-10-06 KR KR1020217009733A patent/KR20210039001A/ko not_active Application Discontinuation
- 2017-10-06 BR BR112019006987-9A patent/BR112019006987B1/pt active IP Right Grant
- 2017-10-06 EP EP21158497.4A patent/EP3851444A1/en not_active Withdrawn
- 2017-10-06 JP JP2019517236A patent/JP6801093B2/ja active Active
- 2017-10-06 DK DK17859300.0T patent/DK3523315T3/da active
-
2019
- 2019-03-26 US US16/365,422 patent/US10472387B2/en active Active
- 2019-04-04 IL IL265835A patent/IL265835B/en active IP Right Grant
- 2019-04-05 MX MX2021010252A patent/MX2021010252A/es unknown
- 2019-09-05 US US16/562,204 patent/US10723759B2/en active Active
-
2020
- 2020-06-01 US US16/889,624 patent/US10836789B2/en active Active
- 2020-07-20 ZA ZA2020/04440A patent/ZA202004440B/en unknown
- 2020-08-05 AU AU2020213316A patent/AU2020213316B2/en active Active
- 2020-09-30 US US17/039,794 patent/US20210017219A1/en not_active Abandoned
- 2020-11-18 JP JP2020191820A patent/JP2021046409A/ja not_active Ceased
-
2021
- 2021-03-31 AU AU2021202016A patent/AU2021202016C1/en active Active
- 2021-06-15 IL IL284005A patent/IL284005A/en unknown
-
2022
- 2022-08-15 US US17/887,777 patent/US20230096870A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284005A (en) | Glucocorticoid receptor inhibitors | |
IL251584B (en) | Dihydropyrrolopyridines ror–gamma inhibitors | |
IL246902A0 (en) | Dihydropyrrolopyridine ror–gamma inhibitors | |
IL257026A (en) | Solid state forms of eluxadoline | |
EP3394078A4 (en) | GLUCOCORTICOID RECEPTOR INHIBITORS | |
GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
IL265628A (en) | Solid state forms of valbenazine | |
EP3394079A4 (en) | INHIBITORS OF GLUCOCORTICOIDREZEPTORS | |
GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
ZA201706282B (en) | Solid forms of menaquinols | |
GB201420627D0 (en) | Application of adhesives | |
IL285700A (en) | 21- Hydroxylation of steroids | |
GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
IL263363A (en) | Polymorph of nintedanib | |
IL264173A (en) | Solid forms of ttk inhibitor | |
IL258573A (en) | Inhibitor of the p2x7 receptor | |
GB201721386D0 (en) | Chrondogy of time-wave | |
ZA201700392B (en) | Construction of pipes | |
ZA201508534B (en) | Construction of pipes |